Beta-2 Adrenergic Receptor (bar2) Polymorphism is Not Associated with Essential Hypertension (ht) in African-Americans (aa) or Caucasian-Americans (Ca).

HG Xie,RB Kim,CM Stein,JV Gainer,NJ Brown,B Leake,AJJ Wood

DOI: https://doi.org/10.1016/s0009-9236(99)80064-2

1999-01-01

Abstract:Clinical Pharmacology & Therapeutics (1999) 65, 133–133; doi:

What problem does this paper attempt to address?

Human Beta(2)-Adrenergic Receptor Polymorphisms: No Association With Essential Hypertension In Black Or White Americans

hongguang xie,c michael stein,richard b kim,james v gainer,g g sofowora,v dishy,nancy j brown,robert e goree,jonathan l haines,alastair j j wood

DOI: https://doi.org/10.1067/mcp.2000.106293

2000-01-01

Clinical Pharmacology & Therapeutics

Abstract:Background and Objectives: The most common polymorphisms of the human beta(2)-adrenergic receptor - Arg16 --> Gly and Gln27 --> Glu - are associated with alterations in beta(2)-adrenergic receptor responses, both in vitro and in vivo. beta(2)-Adrenergic receptor-mediated vascular responses are affected by ethnicity, blood pressure, and genotype. We tested the hypothesis that these two common beta(2)-adrenergic receptor genetic variants are associated with essential hypertension in black or white Americans.Subjects and Methods: In a population-based case-control association study, the relationship between beta(2)-adrenergic receptor genotypes and hypertension was examined in 307 normotensive subjects (128 black and 179 white) and 356 hypertensive subjects (155 black and 201 white). A polymerase chain reaction-based single-stranded conformational polymorphism method with direct sequencing of the bands of interest was used to detect the two frequently occurring beta(2)-adrenergic receptor variants (Arg16-->Gly, Gln27-->Glu).Results: No significant differences in the distributions of alleles and genotypes of the tested beta(2)-adrenergic receptor variants were found between normotensive and hypertensive groups from either black or white Americans (all P >.05). There was a marked interethnic difference in the frequency of the Gln27-->Glu beta(2)-adrenergic receptor polymorphism in both normotensive and hypertensive subjects. Ln normotensive white: subjects, the variant Glu27 allele (35.2% versus 18.0%; P <.0001) and Glu27 homozygous genotype (14.0% versus 4.7%; P <.01) mere more common than in black subjects. Similarly, in hypertensive white subjects, the variant Glu27 allele (35.8% versus 18.4%; P <.0001) and the Glu27 homozygous genotype (15.9% ret sus 2.6%; P <.0001) were more common than in black subjects.Conclusions: These data suggest that although there are marked ethnic differences in their distribution, the common genetic polymorphisms of the human beta(2)-adrenergic receptor gene do not cosegregate with the presence of hypertension in either black or white Americans.
Frequency of Functionally Important Beta-2 Adrenoceptor Polymorphisms Varies Markedly among African-American, Caucasian and Chinese Individuals.

HG Xie,CM Stein,RB Kim,ZS Xiao,N He,HH Zhou,JV Gainer,NJ Brown,JL Haines,AJJ Wood

DOI: https://doi.org/10.1097/00008571-200103000-00009

1999-01-01

Abstract:There are ethnic differences in the prevalence and severity of hypertension and asthma and in beta-2 adrenergic receptor (BAR2)-mediated vascular responses. Two common polymorphisms of the human BAR2, Arg16 to Gly and Gln27 to Glu, are associated with alterations in BAR2 response, both in vitro and in vivo. Ethnic differences in disease manifestations and responses to treatment may be explained by the altered frequency of BAR2 polymorphisms. To determine the relative frequencies of the Arg16 to Gly and Gln27 to Glu BAR2 polymorphisms in different ethnic groups we studied 415 (123 African-American, 188 Caucasian-American and 104 Chinese) healthy individuals. There was a marked interethnic difference in the frequency of the BAR2 polymorphisms among the ethnic groups. The Glu27 allele was more frequent in Caucasian-American (34.8%) than in African-American individuals (20.7%) (P = 0.0001) and much less frequent in Chinese individuals (7.2%) (P = 0.0001 versus African-American or Caucasian-American). The homozygous Glu27 genotype was more frequent in Caucasian-American (15.4%) than African-American individuals (4.9%) (P = 0.003) and was not observed in Chinese. The Gly16 allele (54.3% versus 41.3%) and homozygous genotype (35.1% versus 18.3%) were more common in Caucasian-American than Chinese individuals (P = 0.003 for both). There is a marked ethnic difference in the frequency of these two common BAR2 polymorphisms among African-American, Caucasian-American and Chinese individuals, with a markedly reduced frequency of the Glu27 polymorphism, the polymorphism associated with resistance to desensitization and increased BAR2 responses, in African-American and Chinese individuals. Such ethnic genotypic differences may explain previously observed alterations in the response to the BAR agonists in different ethnic groups.
Ethnic Variability in the Frequency of Alpha(2b)-Adrenergic Receptor Gene (adra2b) Polymorphism.

HG Xie,M Muszkat,G Sofowora,R Landau,WM Cai,RB Kim,RM Smiley,CM Stein,AJJ Wood

DOI: https://doi.org/10.1016/s0009-9236(03)90402-4

2003-01-01

Clinical Pharmacology & Therapeutics

Abstract:Clinical Pharmacology & Therapeutics (2003) 73, P12–P12; doi:
A46G AND C79G POLYMORPHISMS IN BETA2-ADRENERGIC RECEPTOR GENE (ADRB2) AND ESSENTIAL HYPERTENSION RISK: A META-ANALYSIS: PP.21.327

S Wen,Y Lou,J Liu,Y Huang,Z Wang,Y Liu,Z Li,Y Li,Y Xie

DOI: https://doi.org/10.1097/01.hjh.0000379253.37539.28

IF: 4.9

2010-01-01

Journal of Hypertension

Abstract:Objective: No clear consensus has been reached on the β2-adrenergic receptor polymorphisms (A46G and C79G) and essential hypertension risk. We performed a meta-analysis to summarize the possible association. Methods From 301 reports, we included 18 articles (20 studies) at the inclusion criteria. The fixed-effects model and the random-effects model were applied for dichotomous outcomes to combine the results of the individual studies. Results: There was no statistical association between A46G and hypertension risk in all subjects, Asians or Caucasians. However, the association was observed in dominant genetic model (AA vs. (AG + GG)) (P = 0.04, OR = 1.38, 95% CI [1.01–1.87], Pheterogeneity = 0.98) in the subgroup of the mixed Africans. No statistical association could be found between C79G and hypertension risk in overall or any ethnic subgroup. In the research conducted on the severe hypertension (SBP ≥160mmHg and/or DBP≥95mmHg hypertensive population), significant association could be found in dominant genetic model (CC vs. (CG + GG)) (P = 0.04, OR = 1.38, 95% CI [1.02 - 1.86], Pheterogeneity = 0.03), and there was also a boardline significance between the C79 allele and severe hypertension (P = 0.05, OR = 1.26, 95% CI [1.00–1.57], Pheterogeneity = 0.04). No association could be found in the study between these two polymorphisms and stage 2 hypertension. Conclusion Significant association between ADRB2 A46G polymorphism and hypertension was found in the population of the mixed African. The ADRB2 C79G polymorphism has significant association with the SBP ≥160 mmHg and/or DBP ≥95 mmHg hypertensive population.
Differences in the Frequency of Arg492→Cys Polymorphism of the Human Α1a-Adrenergic Receptor (Α1a-Ar) in African-Americans (AA) and Caucasians (CA)

RB Kim,HG Xie,CM Stein,JV Gainer,NJ Brown,AJJ Wood

DOI: https://doi.org/10.1016/s0009-9236(99)80346-4

1999-01-01

Abstract:Clinical Pharmacology & Therapeutics (1999) 65, 204–204; doi:
Effect of the alpha2C-adrenoreceptor deletion322-325 variant on sympathetic activity and cardiovascular measures in healthy subjects.

Daniel Kurnik,Mordechai Muszkat,Eitan A Friedman,Gbenga G Sofowora,André Diedrich,Hong-Guang Xie,Paul A Harris,Leena Choi,Alastair J J Wood,C Michael Stein

IF: 4.9

2007-01-01

Journal of Hypertension

Abstract:BACKGROUND:The alpha2C-adrenergic receptor plays an important role in the regulation of the sympathetic nervous system and, therefore, blood pressure and heart rate. A deletion polymorphism in its gene (ADRA2C del322-325), ten times more common in black than white Americans, has been associated with a loss of function in vitro and, under controlled study conditions, raised blood pressure and catecholamine secretion. We therefore examined the hypothesis that the ADRA2C deletion variant would alter sympathetic activity and contribute to ethnic differences in blood pressure. METHODS:We measured resting plasma norepinephrine and epinephrine concentrations, blood pressure and heart rate in 224 healthy subjects (127 whites), and determined their ADRA2C del322-325 genotype. Additionally, we analyzed heart rate variability (HRV) in a subgroup of 50 black subjects. RESULTS:Systolic (SBP) and diastolic blood pressure (DBP) were higher in blacks than whites [difference (95% confidence interval), 4.4 (1.5-7.4) mmHg, P = 0.003; and 2.7 (0.7-4.6) mmHg, P = 0.01, respectively]. Norepinephrine concentrations did not differ among subjects with 0, 1 and 2 copies of the deletion variant [median (interquartile range), 185.0 (147.5-269.8), 200.0 (154.9-257.0) and 173.8 (158.5-235.8) pg/ml, respectively; P = 0.54]. Similarly, none of the HRV parameters differed among the genotype groups. In multiple linear regression analyses adjusting for multiple covariates, the deletion genotype was not associated with SBP or DBP. In contrast, black ethnicity was associated with higher SBP (P = 0.001) and DBP (P = 0.005). CONCLUSION:The ADRA2C deletion polymorphism had no effect on markers of resting sympathetic activity and cardiovascular measures, and did not account for ethnic differences in blood pressure.
Arg(389)Gly Beta(1)-Adrenoceptor Polymorphism Varies in Frequency among Different Ethnic Groups but Does Not Alter Response in Vivo

HG Xie,V Dishy,G Sofowora,RB Kim,R Landau,RM Smiley,HH Zhou,AJJ Wood,P Harris,CM Stein

DOI: https://doi.org/10.1097/00008571-200104000-00002

2001-01-01

Pharmacogenetics

Abstract:There are marked interethnic differences in beta (1)-adrenclceptor-mediated responsiveness, with sensitivity decreased in African-Americans and increased in Chinese compared with Caucasians, Therefore, the frequency of a common naturally occurring polymorphism of the human beta (1)-adrenoceptor gene (Arg(389)Gly), which has functional importance in vitro, was determined in 194 African-Americans, 316 Caucasian-Americans, 221 Hispanic-Americans and 142 Chinese. African-Americans were found to hare a significantly lower frequency of the Arg(389) allele than the other three ethnic groups (all P < 0.01), In the populations studied, the order of the distribution of the Arg(389) allele was: Chinese (74%) > Caucasians (72%) > Hispanics (67%) > African-Americans (58%). To determine the functional significance of the Arg(389)Gly beta (1)-adrenoceptsr polymorphism in-vivo heart rate responses to exercise were compared in healthy subjects homozygous for the Arg (n = 9) and Gly (n = 8) alleles, Heart rate response to exercise was not affected by genotype (P = 0.4). Although ethnic differences in the frequency of the beta (1)-adrenoceptor Arg(389)Gly polymorphism exist, the polymorphism does Hot appear to have functional significance in healthy subjects and therefore may not contribute to ethnic differences in response to drugs acting through the beta (1)-adrenoceptor, Pharmacogenetics 11:191-197 (C); 2001 Lippincott Williams & Wilkins.
A Common Beta(1)-Adrenergic Receptor Polymorphism (Arg389gly) Affects Blood Pressure Response To Beta-Blockade

g g sofowora,v dishy,m muszkat,h g xie,richard b kim,paul a harris,harish c prasad,daniel w byrne,usha b nair,alastair j j wood,c m stein

DOI: https://doi.org/10.1016/S0009-9236(02)17734-4

2003-01-01

Clinical Pharmacology & Therapeutics

Abstract:Background. A common polymorphism of the beta(1)-adrenergic receptor Arg389Gly markedly affects function in vitro, but little is known about its in vivo significance.Methods and Results: Resting and exercise hemodynamic responses were measured in subjects homozygous for Arg389 (n = 21) or Gly389 (n = 13) alleles before and 3 hours after administration of a beta-blocker, atenolol. Demographic characteristics and atenolol concentrations were similar in the two genotypic groups. Genotype had a marked effect on resting hemodynamic responses to atenolol, with Arg389-homozygous subjects having a larger decrease in resting systolic blood pressure (8.7 +/- 1.3 mm Hg versus 0.2 +/- 1.7 mm Hg, P < .001) and mean arterial blood pressure (7.2 +/- 1.0 mm Hg versus 2.0 1.7 mm Hg, P = .009). Attenuation of exercise-induced hemodynamic responses by atenolol was not affected by genotype.Conclusions. There is reduced sensitivity of Gly389 homozygotes to a beta-adrenergic receptor antagonist, and this polymorphism may be an important determinant of variability in response to P-blockade.
Effect of the Alpha 2(C)-Adrenoreceptor Deletion322-325 Variant on Sympathetic Activity and Cardiovascular Measures in Healthy Subjects

Leena Choi

DOI: https://doi.org/10.1097/hjh.0b013e328017f6e9

IF: 4.9

2007-01-01

Journal of Hypertension

Abstract:BACKGROUND:The alpha2C-adrenergic receptor plays an important role in the regulation of the sympathetic nervous system and, therefore, blood pressure and heart rate. A deletion polymorphism in its gene (ADRA2C del322-325), ten times more common in black than white Americans, has been associated with a loss of function in vitro and, under controlled study conditions, raised blood pressure and catecholamine secretion. We therefore examined the hypothesis that the ADRA2C deletion variant would alter sympathetic activity and contribute to ethnic differences in blood pressure.METHODS:We measured resting plasma norepinephrine and epinephrine concentrations, blood pressure and heart rate in 224 healthy subjects (127 whites), and determined their ADRA2C del322-325 genotype. Additionally, we analyzed heart rate variability (HRV) in a subgroup of 50 black subjects.RESULTS:Systolic (SBP) and diastolic blood pressure (DBP) were higher in blacks than whites [difference (95% confidence interval), 4.4 (1.5-7.4) mmHg, P = 0.003; and 2.7 (0.7-4.6) mmHg, P = 0.01, respectively]. Norepinephrine concentrations did not differ among subjects with 0, 1 and 2 copies of the deletion variant [median (interquartile range), 185.0 (147.5-269.8), 200.0 (154.9-257.0) and 173.8 (158.5-235.8) pg/ml, respectively; P = 0.54]. Similarly, none of the HRV parameters differed among the genotype groups. In multiple linear regression analyses adjusting for multiple covariates, the deletion genotype was not associated with SBP or DBP. In contrast, black ethnicity was associated with higher SBP (P = 0.001) and DBP (P = 0.005).CONCLUSION:The ADRA2C deletion polymorphism had no effect on markers of resting sympathetic activity and cardiovascular measures, and did not account for ethnic differences in blood pressure.
Relationship Between Bradykinin B1 Receptor Gene Polymorphism And Antihypertensive Therapy

YU Yun-fu,LI Ling,CHEN Kui,WU Zhao-ke,ZHANG Jin-ying,FAN Xiao-han,HUI Ru-tai

DOI: https://doi.org/10.3969/j.issn.1671-6272.2006.01.007

2006-01-01

Abstract:Objective To investigate the 1098A/G gene polymorphism of the human bradykinin B1 receptor in essential hypertensive female patients and the relationship between 1098A/G gene polymorphism and antihypertensive response to ACEI. Methods One hundred fifty female patients with essential hypertensive were received ACEI for four weeks and compare with reduction of BP in different genomic . The 1098A/G was genotyped by the polymerase chain reaction combined with restriction enzyme digestion methods. Results the genotype frequencies were 78.5% ,19.6%,1.9% for AA ,GA,GG, respectively; The reduction of SBP in patients carrying AA and GA + GG were 25. 21±13. 69 mmHg and 34. 50±12. 56 mm-Hg, respectively. A significant difference greater in patients among the two groups was found (P<0.05) . Conclusion The reduction of SBP was significantly greater in patients with the G allele, suggesting that the 1098 A/G polymorphism of human bradykinin B1 receptor extron was possibly related to the response to ACEI in essential hypertensive patients.
Variation in the Alpha2b-Adrenergic Receptor Gene (ADRA2B) and Its Relationship to Vascular Response in Vivo.

M Muszkat,D Kurnik,J Solus,GG Sofowora,HG Xie,L Jiang,C McMunn,P Ihrie,JR Harris,EP Dawson,SM Williams,AJJ Wood,CM Stein

DOI: https://doi.org/10.1097/01213011-200506000-00006

2005-01-01

Pharmacogenetics and Genomics

Abstract:The alpha(2B)-adrenergic receptor (ADRA2B) plays an important role in vasoconstriction and blood pressure regulation. One common variant in the ADRA2B gene (del301-303) has been identified, and results in markedly decreased receptor desensitization in vitro but does not alter vascular sensitivity in vivo. Therefore, we fully characterized genetic variations in ADRA2B and related them to phenotype in vivo. We examined 5812 bp of contiguous sequence of ADRA2B (promoter, exonic, and 3'-untranslated region; 3'-UTR) using the polymerase chain reaction to amplify the genomic target followed by bidirectional sequencing (n = 68). Haplotypes were inferred using an expectation maximization algorithm. Vasoconstriction in response to increasing doses of the highly selective alpha(2)-adrenergic receptor agonist, dexmedetomidine (0.01-1000 ng/min) was measured in the dorsal hand vein using a linear variable differential transformer. The dose that produced 50% (ED50) of maximum venoconstriction (E-max) was determined for each subject from the individual dose-response curves. ED50 and Emax were compared in subjects with and without variant alleles and haplotypes of interest. We identified 24 variable sites, 12 in the promoter region, five in the coding region (including two previously described as non-synonymous variants) and seven in the 3'-UTR region. Four haplotypes were inferred, representing approximately 95% of the cohort. One haplotype, characterized by two single nucleotide polymorphisms in the promoter region, and one in the 3'-UTR, occurred in seven of 38 African-Americans, and was associated with a lower E-max, 61.3% [95% confidence interval (CI) 39.5-83.0, n = 7] compared to 78.1% (CI 73.8-82.5) in wild-types (n = 61) (P = 0.02). There was no association between the nine common variants and dexmedetomidine ED50. We have described novel variants and haplotypes of the ADRA2B gene. These do not alter sensitivity to a selective alpha(2)-adrenergic receptor agonist but some may decrease maximal venoconstriction in vivo. (c) 2005 Lippincott Williams & Wilkins.
A46G and C79G polymorphisms in the β2-adrenergic receptor gene ( ADRB2 ) and essential hypertension risk: a meta-analysis

Yuqing Lou,Jinghua Liu,Yan Huang,Jielin Liu,Zuoguang Wang,Ya Liu,Zhizhong Li,Yao Li,Yi Xie,Shaojun Wen

DOI: https://doi.org/10.1038/hr.2010.151

2010-01-01

Hypertension Research

Abstract:No consensus has been reached on the association between the β2-adrenergic receptor polymorphisms A46G and C79G and essential hypertension risk. We performed a meta-analysis to confirm the possible association. After reviewing 303 reports in PubMed and 359 reports in Embase, we included in our meta-analysis 18 articles (20 studies) that met our inclusion criteria. The fixed-effects model and the random-effects model were applied for dichotomous outcomes to combine the results of the individual studies. There was no statistical association between A46G and hypertension risk in all subjects, Asians or Caucasians. However, an association was observed in the dominant genetic model (AA vs . (AG+GG)) ( P =0.04, odds ratio (OR)=1.38, 95% confidence interval (CI) 1.01–1.87, P heterogeneity =0.98, fixed-effects model) in the subgroup of mixed Africans. No overall statistical association could be found between C79G and hypertension risk or any ethnic subgroup. In the research conducted on severe hypertension (systolic blood pressure ⩾160 mm Hg and/or diastolic blood pressure ⩾95 mm Hg hypertensive population), significant association was found in the dominant genetic model (CC vs. (CG+GG)) ( P =0.04, OR=1.38, 95% CI 1.02–1.86, P heterogeneity =0.03, random-effects model), and there was also a borderline significance between the C79 allele and severe hypertension ( P =0.05, OR=1.26, 95% CI 1.00–1.57, P heterogeneity =0.04, random-effects model). No association could be found in this study between the two polymorphisms and stage 2 hypertension. More studies stratified for different ethnicities and different stages of hypertension should be performed in the future.
Beta2 Adrenoceptor Thr164ile Polymorphism is Associated with Markedly Decreased Vasodilator and Increased Vasoconstrictor Sensitivity in Vivo.

V Dishy,R Landau,GG Sofowora,HG Xie,RM Smiley,RB Kim,DW Byrne,AJJ Wood,CM Stein

DOI: https://doi.org/10.1016/s0009-9236(03)90360-2

2003-01-01

Clinical Pharmacology & Therapeutics

Abstract:Clinical Pharmacology & Therapeutics (2003) 73, P1–P1; doi:
Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.

Daniel Kurnik,Chun Li,Gbenga G Sofowora,Eitan A Friedman,Mordechai Muszkat,Hong-Guang Xie,Paul A Harris,Scott M Williams,Usha B Nair,Alastair J J Wood,C Michael Stein

DOI: https://doi.org/10.1097/FPC.0b013e328309733f

2008-01-01

Pharmacogenetics and Genomics

Abstract:Objectives Black patients may be less responsive to beta-blockers than whites. Genetic variants in the beta(1)-adrenergic receptor (beta(1)-AR) associated with lesser response to beta-blockers are more common in blacks than in whites. The purpose of this study was to determine whether ethnic differences in response to beta-blockade can be explained by differing distributions of functional genetic variants in the beta(1)-AR. Methods We measured sensitivity to beta-blockade by the attenuation of exercise-induced tachycardia in 165 patients (92 whites), who performed a graded bicycle exercise test before and 2.5 h after oral atenolol (25 mg). We determined heart rate at rest and at three exercise levels from continuous ECG recordings and calculated the area under the curve. We also measured plasma atenolol concentrations and determined genotypes for variants of the beta(1)-AR (Ser49Gly, Arg389Gly) and alpha(2C)-AR (del322-325). The effects of ethnicity, genotype, and other covariates on the heart rate reduction after atenolol were estimated in multiple regression analyses. Results Atenolol resulted in a greater reduction in exercise heart rate in whites than in blacks (P = 0.006). beta(1)-AR Arg389 (P = 0.003), but not the alpha(2C)-AR 322-325 insertion allele (P = 0.31), was independently associated with a greater reduction in heart rate area under the curve. Ethnic differences in sensitivity to atenolol remained significant (P = 0.006) after adjustment for beta(1)-AR and alpha(2C)-AR genotypes. Conclusion Ethnic differences in sensitivity to the beta(1)-blocker atenolol persist even after accounting for different distributions of functional genetic beta(1)-AR variants, suggesting that additional, as yet unidentified factors contribute to such ethnic differences.
Alpha 1A-adrenergic receptor polymorphism and vascular response.

Gbenga G Sofowora,Victor Dishy,Ruth Landau,Hong-Guang Xie,Harish C Prasad,Daniel W Byrne,Richard M Smiley,Richard B Kim,Alastair J J Wood,C Michael Stein

2004-01-01

Abstract:We conclude that the Arg347Cys receptor polymorphism does not alter agonist-mediated venoconstriction in vivo.
A 9‐base Pair Deletion Polymorphism in the Alpha2b‐adrenergic Receptor Gene (ADRA2B) is Not Associated with Pre‐eclampsia or Pre‐term Labor

HG Xie,R Landau,RM Smiley,RB Kim,AJJ Wood,CM Stein

DOI: https://doi.org/10.1016/s0009-9236(03)90401-2

2003-01-01

Abstract:Clinical Pharmacology & Therapeutics (2003) 73, P12–P12; doi:
Β2adrenergic Receptor GeneArg16GlyPolymorphism is Associated with Therapeutic Efficacy of Benazepril on Essential Hypertension in Chinese

G Huang,HX Xing,K Hao,SJ Peng,D Wu,WW Guang,AQ Huang,XM Hong,YP Wang,Y Feng,Y Zhang,JP Li,CZ Chen,GY Wang,Y Huo,DF Chen,YT Hou,XB Wang,X Xu,TH Niu,XP Xu

DOI: https://doi.org/10.1081/ceh-200031839

2004-01-01

Clinical and Experimental Hypertension

Abstract:Background: There is considerable variability in individual response to antihypertensive agents. The reason for this is not known, but may be related to individual genetic variability. This study examined whether the therapeutic efficacy of benazepril on essential hypertension is modified by β2 adrenergic receptor gene (ADRB2) Arg16Gly (R16G) polymorphism. Methods and Results: We conducted a family‐based study of 321 and 610 hypertensive subjects from Yuexi and Huoqiu Counties of Anhui, China, respectively. Both systolic and diastolic blood pressures (SBP and DBP) before and after a 15‐day benazepril treatment were measured. ADRB2 R16G genotypes were determined for all subjects. ADRB2 G16 allele frequency was found to be 41.0% and. 47.4% in Huoqiu and Yuexi, respectively. In Yuexi family‐based association test (FBAT) revealed that the G16 allele was associated with a greater DBP decrease in response to a 15‐day benazepril treatment (Z = 2.12, P = 0.03), and the data were consistent with a dominant inheritance model. A similar trend was observed in Huoqiu Chinese, but the magnitudes of effects were smaller and did not reach statistical significance. The FBAT results were further confirmed by using a generalized estimating equation model. Conclusion: Our family‐based study provided the first evidence that ADRB2 R16G polymorphism may play an important role in DBP response to benazepril treatment, although the magnitude of the effect appears to be modified by other risk factors such as plasma lipid and glucose profiles.
[Association of Single Nucleotide Polymorphisms in Code Region of Beta2-Adrenoceptor Gene with Hypertension in Chinese Population].

H Wu,G Cai,H Chen,J Xiao,W Huang,D Lu,J Xue,L Jin

DOI: https://doi.org/10.3760/j.issn:0578-1426.2001.01.009

2001-01-01

Abstract:OBJECTIVE:To detect single nucleotide polymorphisms(SNPs) existing in code region of beta(2)-adrenoceptor(2-AR) gene and to investigate association of the identified SNPs with essential hypertension in Chinese Han population.METHODS:Beta(2)-AR gene was sequenced with fluorescent labelling automatic sequencing method in unrelated Chinese Han population from Dabie Mountain in Anhui Province. Genotype of the SNPs were typed with PCR-RFLP method.RESULTS:Two SNPs were identified in length of 774bp, at position + 1053 with G-->C substitution and + 1239 with A-->G substitution respectively. The frequency of genotype of the two SNPs complied well with the Hardy-Weinberg equilibrium in normal group. Distribution of genotype AA, GA, GG of the SNPs at locus + 1239 in hypertension group was significantly different from that in normal group (chi(2) = 6.70, df = 2, P < 0.05). No significant difference was observed in distribution of genotypes of the SNPs at locus + 1053 between the two groups.CONCLUSION:These results indicate that the SNPs at locus + 1239 of beta(2)-AR gene is associated with EH. The SNPs at position + 1053 was not linked to hypertension.
Relationship Between Genetic Polymorphisms of Β2-Adrenergic Receptor Gene and Essential Hypertension Risk among the Han Chinese Population: a Meta Analysis

Yu-qing Lou,Ya Liu,Hai Wu,Zuo-guang Wang,Kuo Liu,Yao Li,Zhi-zhong Li,Shao-jun Wen

DOI: https://doi.org/10.3760/cma.j.issn.0253-9624.2011.02.009

2011-01-01

Abstract:OBJECTIVE:To evaluate the relationship between A46G and C79G polymorphisms in the β2-adrenergic receptor (ADRB2) gene and the incidence of essential hypertension (EH) among the Han Chinese population.METHODS:We conducted a computer retrieval of PUBMED, EMBASE, CNKI, Wanfang and VIP databases prior to May 2010. Articles investigating the relationship of EH and ADRB2 gene polymorphism of Han group were found through literature search, including 15 articles on A46G and 10 articles on C79G. According to the including and excluding criteria, a Meta-analysis was conducted in EH and ADRB2 gene polymorphism of A46G and C79G. The association was examined by RevMan4.2 software through quantitative analysis.RESULTS:Eight articles on A46G polymorphism (including 1078 EH cases and 788 control subjects) and six articles on C79G polymorphism (including 1367 EH cases and 1006 control subjects) were included in the current study. Meta-analysis showed that there was a significant association between A46G polymorphism and EH: genotype GG/(AA + AG) (fixed-effected model, OR = 1.35, 95%CI = 1.04 - 1.74, P = 0.02), genotype GG/AA (fixed-effected model, OR = 1.41, 95%CI = 1.06 - 1.89, P = 0.02). No significant association was found between C79G polymorphism and EH of Han group in China: G/C allele comparison (random-effected model, OR = 0.88, 95%CI = 0.55 - 1.39, P = 0.57).CONCLUSION:Significant association was found between A46G polymorphism of ADRB2 gene and EH, whereas no association could be found between C79G polymorphism and EH among Han Chinese population.
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.

V Dishy,G G Sofowora,H G Xie,R B Kim,D W Byrne,C M Stein,A J Wood

2001-01-01

Abstract:The Arg16 polymorphism of the beta2-adrenergic receptor is associated with enhanced agonist-mediated desensitization in the vasculature, and the Glu27 polymorphism is associated with increased agonist-mediated responsiveness. Therefore, polymorphisms of the beta2-adrenergic receptor are potentially important determinants of the vascular response to stress.

Beta-2 Adrenergic Receptor (bar2) Polymorphism is Not Associated with Essential Hypertension (ht) in African-Americans (aa) or Caucasian-Americans (Ca).

Human Beta(2)-Adrenergic Receptor Polymorphisms: No Association With Essential Hypertension In Black Or White Americans

Frequency of Functionally Important Beta-2 Adrenoceptor Polymorphisms Varies Markedly among African-American, Caucasian and Chinese Individuals.

Ethnic Variability in the Frequency of Alpha(2b)-Adrenergic Receptor Gene (adra2b) Polymorphism.

A46G AND C79G POLYMORPHISMS IN BETA2-ADRENERGIC RECEPTOR GENE (ADRB2) AND ESSENTIAL HYPERTENSION RISK: A META-ANALYSIS: PP.21.327

Differences in the Frequency of Arg492→Cys Polymorphism of the Human Α1a-Adrenergic Receptor (Α1a-Ar) in African-Americans (AA) and Caucasians (CA)

Effect of the alpha2C-adrenoreceptor deletion322-325 variant on sympathetic activity and cardiovascular measures in healthy subjects.

Arg(389)Gly Beta(1)-Adrenoceptor Polymorphism Varies in Frequency among Different Ethnic Groups but Does Not Alter Response in Vivo

A Common Beta(1)-Adrenergic Receptor Polymorphism (Arg389gly) Affects Blood Pressure Response To Beta-Blockade

Effect of the Alpha 2(C)-Adrenoreceptor Deletion322-325 Variant on Sympathetic Activity and Cardiovascular Measures in Healthy Subjects

Relationship Between Bradykinin B1 Receptor Gene Polymorphism And Antihypertensive Therapy

Variation in the Alpha2b-Adrenergic Receptor Gene (ADRA2B) and Its Relationship to Vascular Response in Vivo.

A46G and C79G polymorphisms in the β2-adrenergic receptor gene ( ADRB2 ) and essential hypertension risk: a meta-analysis

Beta2 Adrenoceptor Thr164ile Polymorphism is Associated with Markedly Decreased Vasodilator and Increased Vasoconstrictor Sensitivity in Vivo.

Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.

Alpha 1A-adrenergic receptor polymorphism and vascular response.

A 9‐base Pair Deletion Polymorphism in the Alpha2b‐adrenergic Receptor Gene (ADRA2B) is Not Associated with Pre‐eclampsia or Pre‐term Labor

Β2adrenergic Receptor GeneArg16GlyPolymorphism is Associated with Therapeutic Efficacy of Benazepril on Essential Hypertension in Chinese

[Association of Single Nucleotide Polymorphisms in Code Region of Beta2-Adrenoceptor Gene with Hypertension in Chinese Population].

Relationship Between Genetic Polymorphisms of Β2-Adrenergic Receptor Gene and Essential Hypertension Risk among the Han Chinese Population: a Meta Analysis

The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.